Thymidine kinase-1 as a biomarker in breast cancer: estimating prognosis and early recognition of treatment resistance

Biomark Med. 2020 May;14(7):495-498. doi: 10.2217/bmm-2020-0072. Epub 2020 May 7.
No abstract available

Keywords: CDK4/6; TK1; biomarker; breast cancer; endocrine therapy; luminal, prognosis; metastatic; resistance; thymidine kinase-1.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / metabolism*
  • Breast Neoplasms / diagnosis*
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / metabolism*
  • Clinical Trials as Topic
  • Drug Resistance, Neoplasm*
  • Humans
  • Thymidine Kinase / metabolism*

Substances

  • Biomarkers, Tumor
  • Thymidine Kinase